A Prospective, Phase 4, Open-Label, Twelve-Week Study to Examine the Cognitive Impact and Tolerability of Levetiracetam (Keppra) in Elderly Patients With Seizures of Partial Onset.

Trial Profile

A Prospective, Phase 4, Open-Label, Twelve-Week Study to Examine the Cognitive Impact and Tolerability of Levetiracetam (Keppra) in Elderly Patients With Seizures of Partial Onset.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2015

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Dementia; Seizures
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 24 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top